using rifampin WITH pyrazinamide for latent tuberculosis

There are new warnings about using rifampin WITH pyrazinamide for latent tuberculosis.

Since the CDC recommended the combo last year, there have been 23 cases of liver injury...twice the amount seen with other regimens.

Now the CDC recommends patient evaluations every two weeks when using rifampin with pyrazinamide for latent TB...and to avoid the combo in patients with liver disease or previous isoniazid hepatotoxicity.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote